kabutan

SHIN NIPPON BIOMEDICAL, 8% Decrease in Ordinary Profit for The Current Fiscal Year

Thu May 8, 2025 11:30 am JST Earnings

2395 SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. 【J-GAAP】

Earnings Report

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. <2395> [TSE Prime] announced its financial results at noon (11:30) on May 8th. The consolidated ordinary profit for the fiscal year ending March 2025 decreased 8.1% from the previous period to 6.45 billion yen. For the fiscal year ending March 2026, the consolidated ordinary profit is expected to decrease by 8.1% from the previous period to 5.92 billion yen. This will be the third consecutive term of declining profits.

In the most recent three-month period, from January to March (4Q), the consolidated ordinary profit grew 8.5% from the same period last year, reaching 2.31 billion yen. However, the operating profit margin significantly dropped from 19.2% in the same period last year to 10.7%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 25,090 5,245 9,194 6,060 145.6 50 May 8, 2023 J-GAAP
Mar, 2024 26,450 4,162 7,015 5,531 132.9 50 May 8, 2024 J-GAAP
Mar, 2025 32,413 2,985 6,450 4,924 118.3 50 May 8, 2025 J-GAAP
YoY +22.5% -28.3% -8.1% -11.0% -11.0%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Guidance 32,000 2,900 5,900 4,400 105.7 50 Feb 5, 2025 J-GAAP
Mar, 2025 Results 32,413 2,985 6,450 4,924 118.3 50 May 8, 2025 J-GAAP
Revision Rate +1.3% +2.9% +9.3% +11.9% +11.9%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 12,508 80 1,829 1,331 32.0 20 Nov 6, 2024 J-GAAP
Apr - Sep, 2025 Guidance 14,542 -97 1,180 -183 -4.4 20 May 8, 2025 J-GAAP
YoY +16.3% － -35.5% － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 26,450 4,162 7,015 5,531 132.9 50 May 8, 2024 J-GAAP
Mar, 2025 32,413 2,985 6,450 4,924 118.3 50 May 8, 2025 J-GAAP
Mar, 2026 Guidance 33,272 3,550 5,927 3,550 85.3 50 May 8, 2025 J-GAAP
YoY +2.7% +18.9% -8.1% -27.9% -27.9%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Jan - Mar, 2024 8,466 1,627 2,131 1,737 41.7 19.2 May 8, 2024 J-GAAP
Apr - Jun, 2024 5,549 -145 342 122 2.9 -2.6 Aug 6, 2024 J-GAAP
Jul - Sep, 2024 6,959 225 1,487 1,209 29.0 3.2 Nov 6, 2024 J-GAAP
Oct - Dec, 2024 9,727 1,813 2,309 1,874 45.0 18.6 Feb 5, 2025 J-GAAP
Jan - Mar, 2025 10,178 1,092 2,312 1,719 41.3 10.7 May 8, 2025 J-GAAP
YoY +20.2% -32.9% +8.5% -1.0% -1.0%

Related Articles